S&P 500   3,117.43 (+0.15%)
DOW   27,677.79 (+0.10%)
QQQ   202.83 (+0.20%)
AAPL   265.58 (+1.47%)
FB   199.36 (+0.33%)
MSFT   149.93 (+0.05%)
GOOGL   1,326.96 (+0.61%)
AMZN   1,740.48 (-1.15%)
CGC   18.60 (+1.20%)
NVDA   208.74 (-0.32%)
MU   46.62 (+0.69%)
BABA   200.00 (+3.23%)
GE   10.79 (-1.01%)
TSLA   330.37 (-0.80%)
T   38.19 (+0.24%)
AMD   39.62 (-0.18%)
ACB   2.44 (-1.61%)
F   8.93 (-0.22%)
PRI   134.30 (+0.83%)
NFLX   302.86 (-0.48%)
BAC   33.09 (-0.18%)
GILD   65.93 (-1.23%)
DIS   147.44 (-0.57%)
S&P 500   3,117.43 (+0.15%)
DOW   27,677.79 (+0.10%)
QQQ   202.83 (+0.20%)
AAPL   265.58 (+1.47%)
FB   199.36 (+0.33%)
MSFT   149.93 (+0.05%)
GOOGL   1,326.96 (+0.61%)
AMZN   1,740.48 (-1.15%)
CGC   18.60 (+1.20%)
NVDA   208.74 (-0.32%)
MU   46.62 (+0.69%)
BABA   200.00 (+3.23%)
GE   10.79 (-1.01%)
TSLA   330.37 (-0.80%)
T   38.19 (+0.24%)
AMD   39.62 (-0.18%)
ACB   2.44 (-1.61%)
F   8.93 (-0.22%)
PRI   134.30 (+0.83%)
NFLX   302.86 (-0.48%)
BAC   33.09 (-0.18%)
GILD   65.93 (-1.23%)
DIS   147.44 (-0.57%)
S&P 500   3,117.43 (+0.15%)
DOW   27,677.79 (+0.10%)
QQQ   202.83 (+0.20%)
AAPL   265.58 (+1.47%)
FB   199.36 (+0.33%)
MSFT   149.93 (+0.05%)
GOOGL   1,326.96 (+0.61%)
AMZN   1,740.48 (-1.15%)
CGC   18.60 (+1.20%)
NVDA   208.74 (-0.32%)
MU   46.62 (+0.69%)
BABA   200.00 (+3.23%)
GE   10.79 (-1.01%)
TSLA   330.37 (-0.80%)
T   38.19 (+0.24%)
AMD   39.62 (-0.18%)
ACB   2.44 (-1.61%)
F   8.93 (-0.22%)
PRI   134.30 (+0.83%)
NFLX   302.86 (-0.48%)
BAC   33.09 (-0.18%)
GILD   65.93 (-1.23%)
DIS   147.44 (-0.57%)
S&P 500   3,117.43 (+0.15%)
DOW   27,677.79 (+0.10%)
QQQ   202.83 (+0.20%)
AAPL   265.58 (+1.47%)
FB   199.36 (+0.33%)
MSFT   149.93 (+0.05%)
GOOGL   1,326.96 (+0.61%)
AMZN   1,740.48 (-1.15%)
CGC   18.60 (+1.20%)
NVDA   208.74 (-0.32%)
MU   46.62 (+0.69%)
BABA   200.00 (+3.23%)
GE   10.79 (-1.01%)
TSLA   330.37 (-0.80%)
T   38.19 (+0.24%)
AMD   39.62 (-0.18%)
ACB   2.44 (-1.61%)
F   8.93 (-0.22%)
PRI   134.30 (+0.83%)
NFLX   302.86 (-0.48%)
BAC   33.09 (-0.18%)
GILD   65.93 (-1.23%)
DIS   147.44 (-0.57%)
Log in

NASDAQ:WMGI - Wright Medical Group Stock Price, Forecast & News

$29.60
-0.25 (-0.84 %)
(As of 12/5/2019 04:00 PM ET)
Today's Range
$29.55
Now: $29.60
$29.87
50-Day Range
$20.02
MA: $26.09
$29.97
52-Week Range
$19.04
Now: $29.60
$32.86
Volume4.67 million shs
Average Volume2.59 million shs
Market Capitalization$3.76 billion
P/E Ratio229.00
Dividend YieldN/A
Beta0.94
Wright Medical Group N.V., a medical device company, designs, manufactures, markets, and sells upper and lower extremities, and biologics products in the United States, Europe, the Middle East, Africa, Canada, Asia, Australia, and Latin America. The company offers joint implants and bone fixation devices for the shoulder, elbow, wrist, hand, foot, and ankle; and biologics products that are used for supporting the treatment of damaged or diseased bones, tendons, and soft tissues, as well as to stimulate bone growth. Read More…

Industry, Sector and Symbol

Industry Surgical appliances & supplies
Sub-IndustryHealth Care Equipment
SectorMedical
Current SymbolNASDAQ:WMGI
CUSIPN8723710
Phone31-20-521-4777

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$836.19 million
Cash Flow$1.12 per share
Book Value$7.45 per share

Profitability

Net Income$-169,510,000.00

Miscellaneous

Employees2,894
Market Cap$3.76 billion
Next Earnings Date2/25/2020 (Estimated)
OptionableOptionable

Receive WMGI News and Ratings via Email

Sign-up to receive the latest news and ratings for WMGI and its competitors with MarketBeat's FREE daily newsletter.


Wright Medical Group (NASDAQ:WMGI) Frequently Asked Questions

What is Wright Medical Group's stock symbol?

Wright Medical Group trades on the NASDAQ under the ticker symbol "WMGI."

How often does Wright Medical Group pay dividends? What is the dividend yield for Wright Medical Group?

Wright Medical Group declared a dividend on Tuesday, December 11th. Shareholders of record on Wednesday, December 5th will be given a dividend of $1.50 per share on Monday, December 10th. The ex-dividend date is Wednesday, December 12th. View Wright Medical Group's Dividend History.

How were Wright Medical Group's earnings last quarter?

Wright Medical Group NV (NASDAQ:WMGI) posted its quarterly earnings results on Wednesday, August, 8th. The medical device company reported ($0.03) EPS for the quarter, beating analysts' consensus estimates of ($0.06) by $0.03. The medical device company had revenue of $205.40 million for the quarter, compared to analysts' expectations of $197.20 million. Wright Medical Group had a positive return on equity of 1.89% and a negative net margin of 14.49%. The company's quarterly revenue was up 14.3% compared to the same quarter last year. During the same period last year, the company earned ($0.07) EPS. View Wright Medical Group's Earnings History.

When is Wright Medical Group's next earnings date?

Wright Medical Group is scheduled to release their next quarterly earnings announcement on Tuesday, February 25th 2020. View Earnings Estimates for Wright Medical Group.

What price target have analysts set for WMGI?

14 brokerages have issued 12-month target prices for Wright Medical Group's stock. Their forecasts range from $23.00 to $40.00. On average, they anticipate Wright Medical Group's stock price to reach $29.89 in the next year. This suggests a possible upside of 1.0% from the stock's current price. View Analyst Price Targets for Wright Medical Group.

What is the consensus analysts' recommendation for Wright Medical Group?

14 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Wright Medical Group in the last year. There are currently 10 hold ratings and 4 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Wright Medical Group.

What are Wall Street analysts saying about Wright Medical Group stock?

Here are some recent quotes from research analysts about Wright Medical Group stock:
  • 1. Needham & Company LLC analysts commented, "WMGI’s 4Q18 revenue was consistent with its preannouncement while EBITDA and EPS beat consensus. For 2019, management provided revenue, EBITDA, and EPS guidance that all bracketed consensus. Organic revenue growth slowed to 10.1% (adjusted for selling days) from 14.4% in 3Q18 as strong US Lower Extremities growth was offset by slower US Upper Extremities growth (faced its toughest comp of the year). Given the improving Lower Extremities growth, Augment Injectable launch, and Cartiva acquisition, we have increased confidence that WMGI can exceed consensus in 2019 despite some likely moderation in its US Upper Extremities growth and we reiterate our Buy rating." (2/27/2019)
  • 2. Cantor Fitzgerald analysts commented, "We reiterate our Overweight rating and a 12-month price target of $35 on shares of WMGI. We think WMGI is positioned to outperform expectations in 2018 with multiple drivers across each of its three primary segments (lower extremities, upper extremities, and biologics) to accelerate growth. We see WMGI’s valuation as attractive, as we expect innovative products to help WMGI to capitalize on the evolving market trends. Valuation Summary We base our $35 price target on a ~5.5x EV/Sales multiple on our 2019 sales estimate." (12/10/2018)

Has Wright Medical Group been receiving favorable news coverage?

Media coverage about WMGI stock has trended somewhat negative recently, according to InfoTrie Sentiment Analysis. InfoTrie scores the sentiment of media coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Wright Medical Group earned a daily sentiment score of -1.6 on InfoTrie's scale. They also assigned media stories about the medical device company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an impact on the company's share price in the immediate future. View News Stories for Wright Medical Group.

Are investors shorting Wright Medical Group?

Wright Medical Group saw a decline in short interest in the month of November. As of November 15th, there was short interest totalling 16,250,000 shares, a decline of 5.8% from the October 31st total of 17,250,000 shares. Based on an average daily volume of 4,470,000 shares, the short-interest ratio is currently 3.6 days. Currently, 13.0% of the shares of the company are sold short. View Wright Medical Group's Current Options Chain.

Who are some of Wright Medical Group's key competitors?

What other stocks do shareholders of Wright Medical Group own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Wright Medical Group investors own include Exelixis (EXEL), Gilead Sciences (GILD), Immunomedics (IMMU), Vereit (VER), GW Pharmaceuticals PLC- (GWPH), Horizon Therapeutics (HZNP), The Medicines (MDCO), PTC Therapeutics (PTCT), Zoetis (ZTS) and Clovis Oncology (CLVS).

Who are Wright Medical Group's key executives?

Wright Medical Group's management team includes the folowing people:
  • Mr. Robert J. Palmisano, Pres, CEO & Exec. Director (Age 74)
  • Mr. Lance A. Berry, Exec. VP, CFO & COO (Age 47)
  • Mr. Andrew C. Morton, Sr. VP & Chief HR Officer (Age 53)
  • Mr. Kevin D. Cordell, Exec. VP & Chief Global Commercial Officer (Age 53)
  • Mr. Peter S. Cooke, Pres of emerging markets, Australia & Japan (Age 54)

Who are Wright Medical Group's major shareholders?

Wright Medical Group's stock is owned by a number of of institutional and retail investors. Top institutional investors include Orbimed Advisors LLC (3.02%), Fisher Asset Management LLC (2.37%), Redmile Group LLC (1.89%), Eagle Asset Management Inc. (1.16%), GW&K Investment Management LLC (1.03%) and Point72 Asset Management L.P. (0.96%). Company insiders that own Wright Medical Group stock include Andrew C Morton, Barry J Regan, David D Stevens, Elizabeth H Weatherman, James Lightman, Jennifer S Walker, John L Miclot, Jonathan Wesley Porter, Julie Andrews, Julie D Dewey, Kevin C Oboyle, Kevin D Cordell, Lance A Berry, Patrick Fisher, Peter Cooke, Richard F Wallman, Robert J Palmisano, Robert P Burrows III and Tim Lanier. View Institutional Ownership Trends for Wright Medical Group.

Which institutional investors are selling Wright Medical Group stock?

WMGI stock was sold by a variety of institutional investors in the last quarter, including Man Group plc, Barclays PLC, Voya Investment Management LLC, Orbimed Advisors LLC, Peregrine Capital Management LLC, Stifel Financial Corp, Endurant Capital Management LP and Keeley Teton Advisors LLC. Company insiders that have sold Wright Medical Group company stock in the last year include Andrew C Morton, David D Stevens, James Lightman, John L Miclot, Jonathan Wesley Porter, Julie Andrews, Julie D Dewey, Kevin C Oboyle, Kevin D Cordell, Lance A Berry, Patrick Fisher and Tim Lanier. View Insider Buying and Selling for Wright Medical Group.

Which institutional investors are buying Wright Medical Group stock?

WMGI stock was bought by a variety of institutional investors in the last quarter, including Point72 Asset Management L.P., Scopia Capital Management LP, Public Employees Retirement Association of Colorado, GW&K Investment Management LLC, State of New Jersey Common Pension Fund D, Fisher Asset Management LLC, California Public Employees Retirement System and Mitsubishi UFJ Asset Management UK Ltd.. Company insiders that have bought Wright Medical Group stock in the last two years include Barry J Regan, Elizabeth H Weatherman, Richard F Wallman and Robert J Palmisano. View Insider Buying and Selling for Wright Medical Group.

How do I buy shares of Wright Medical Group?

Shares of WMGI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Wright Medical Group's stock price today?

One share of WMGI stock can currently be purchased for approximately $29.60.

How big of a company is Wright Medical Group?

Wright Medical Group has a market capitalization of $3.76 billion and generates $836.19 million in revenue each year. Wright Medical Group employs 2,894 workers across the globe.View Additional Information About Wright Medical Group.

What is Wright Medical Group's official website?

The official website for Wright Medical Group is http://www.wright.com/.

How can I contact Wright Medical Group?

Wright Medical Group's mailing address is PRINS BERNHARDPLEIN 200, AMSTERDAM P7, 1097 JB. The medical device company can be reached via phone at 31-20-521-4777 or via email at [email protected]


MarketBeat Community Rating for Wright Medical Group (NASDAQ WMGI)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  537 (Vote Outperform)
Underperform Votes:  513 (Vote Underperform)
Total Votes:  1,050
MarketBeat's community ratings are surveys of what our community members think about Wright Medical Group and other stocks. Vote "Outperform" if you believe WMGI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe WMGI will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/5/2019 by MarketBeat.com Staff

Featured Article: What is Depreciation?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel